dosimetry

You have access
Feasibility of Single-Time-Point Dosimetry for Radiopharmaceutical Therapies
Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Böning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1006-1011; DOI: https://doi.org/10.2967/jnumed.120.254656
You have access
¹³¹Iodine-GD2-ch14.18 scintigraphy to evaluate option for radioimmunotherapy in patients with advanced tumors
Ying Zhang, Juergen Kupferschlaeger, Peter Lang, Gerald Reischl, Rupert Handgretinger, Christian la Fougere and Helmut Dittmann

Journal of Nuclear Medicine May 28, 2021, jnumed.120.261854; DOI: https://doi.org/10.2967/jnumed.120.261854
You have access
Safety, Biodistribution, and Radiation Dosimetry of ¹⁸F-rhPSMA-7.3 in Healthy Adult Volunteers
Tuula Tolvanen, Kari Kalliokoski, Simona Malaspina, Anna Kuisma, Salla Lahdenpohja, Ernst J. Postema, Matthew P. Miller and Mika Scheinin

Journal of Nuclear Medicine May 10, 2021, 62 (5) 679-684; DOI: https://doi.org/10.2967/jnumed.120.252114
You have access
Deep-Learning Generation of Synthetic Intermediate Projections Improves ¹⁷⁷Lu SPECT Images Reconstructed with Sparsely Acquired Projections
Tobias Rydén, Martijn Van Essen, Ida Marin, Johanna Svensson and Peter Bernhardt

Journal of Nuclear Medicine April 1, 2021, 62 (4) 528-535; DOI: https://doi.org/10.2967/jnumed.120.245548
Open Access
First-in-Humans Study of ⁶⁸Ga-DOTA-Siglec-9, a PET Ligand Targeting Vascular Adhesion Protein 1
Riikka Viitanen, Olli Moisio, Petteri Lankinen, Xiang-Guo Li, Mikko Koivumäki, Sami Suilamo, Tuula Tolvanen, Kirsi Taimen, Markku Mali, Ia Kohonen, Ilpo Koskivirta, Vesa Oikonen, Helena Virtanen, Kristiina Santalahti, Anu Autio, Antti Saraste, Laura Pirilä, Pirjo Nuutila, Juhani Knuuti, Sirpa Jalkanen and Anne Roivainen

Journal of Nuclear Medicine April 1, 2021, 62 (4) 577-583; DOI: https://doi.org/10.2967/jnumed.120.250696
Open Access
Addition Of ¹³¹I MIBG To PRRT (⁹⁰Y DOTATOC) For Personalized Treatment of Selected Patients with Neuroendocrine Tumors
David L. Bushnell, Kellie L. Bodeker, Thomas M. O'Dorisio, Mark T. Madsen, Yusuf Menda, Stephen A Graves, M. Sue O'Dorisio and Gideon K. D. Zamba

Journal of Nuclear Medicine January 30, 2021, jnumed.120.254987; DOI: https://doi.org/10.2967/jnumed.120.254987
You have access
Dose–Effect Relationships of ¹⁶⁶Ho Radioembolization in Colorectal Cancer
Caren van Roekel, Remco Bastiaannet, Maarten L.J. Smits, Rutger C. Bruijnen, Arthur J.A.T. Braat, Hugo W.A.M. de Jong, Sjoerd G. Elias and Marnix G.E.H. Lam

Journal of Nuclear Medicine February 1, 2021, 62 (2) 272-279; DOI: https://doi.org/10.2967/jnumed.120.243832
Open Access
Evaluation of safety and dosimetry of ¹⁷⁷Lu DOTA-ZOL for therapy of bone metastases
Rene Fernandez, Elisabeth Eppard, Wencke Lehnert, Luis David Jimenez-Franco, Cristian Soza-Ried, Matias Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Roesch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral

Journal of Nuclear Medicine January 8, 2021, jnumed.120.255851; DOI: https://doi.org/10.2967/jnumed.120.255851
You have access
Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC using ¹⁹F/¹⁷⁷Lu-rhPSMA-7.3 and ¹⁷⁷Lu-PSMA I&T
Nahid Yusufi, Alexander Wurzer, Michael Herz, Calogero D'Alessandria, Benedikt Feuerecker, Wolfgang Andreas Weber, Hans-Juergen Wester, Stephan G. Nekolla and Matthias Eiber

Journal of Nuclear Medicine December 18, 2020, jnumed.120.254516; DOI: https://doi.org/10.2967/jnumed.120.254516
You have access
A novel time-activity information sharing approach using nonlinear mixed models for patient-specific dosimetry with reduced imaging time points: application in SPECT/CT imaging post-¹⁷⁷Lu-DOTATATE
Theresa Devasia, Yuni K. Dewaraja, Kirk A Frey, Ka Kit Wong and Matthew J Schipper

Journal of Nuclear Medicine December 18, 2020, jnumed.120.256255; DOI: https://doi.org/10.2967/jnumed.120.256255

Main menu

User menu

Search

dosimetry

Pages